CHMP has adopted a positive opinion for Kigabeq®
28 août 2018
Granting of the marketing authorization for Kigabeq®
1 octobre 2018

ORPHELIA Pharma will be present at CPhI in Madrid

Hugues Bienaymé, General Manager and Chief Scientific Officer of ORPHELIA Pharma and Mathieu Schmitt, Pharmaceutical Development Director, will be present to the 2018 CPhI to be held in Madrid, Spain, October 9-11, 2018.
Please meet us there (contact: mathieu.schmitt@orphelia-pharma.eu).